1107938
Last Update Posted: 2010-04-21
Recruiting status is unknown
All Genders accepted | 18 Years-70 Years |
330 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients
This study is designed to evaluate the efficacy and tolerability of ilaprazole relative to that of esomeprazole in healing erosive esophagitis and resolving accompanying symptoms of GERD.
Eligibility
Relevant conditions:
Gastroesophageal Reflux Disease
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
Haitang Hu, MD
wl1020_2000@126.com
+86 13892890474
Data sourced from ClinicalTrials.gov